How to translate text using browser tools
15 February 2023 Presence of ovarian stromal aberrations after cessation of testosterone therapy in a transgender mouse model
Hadrian M. Kinnear, Prianka H. Hashim, Cynthia Dela Cruz, Faith L. Chang, Gillian Rubenstein, Likitha Nimmagadda, Venkateswaran Ramamoorthi Elangovan, Andrea Jones, Margaret A. Brunette, D. Ford Hannum, Jun Z. Li, Vasantha Padmanabhan, Molly B. Moravek, Ariella Shikanov
Author Affiliations +
Abstract

Some transmasculine individuals may be interested in pausing gender-affirming testosterone therapy and carrying a pregnancy. The ovarian impact of taking and pausing testosterone is not completely understood. The objective of this study was to utilize a mouse model mimicking transmasculine testosterone therapy to characterize the ovarian dynamics following testosterone cessation. We injected postpubertal 9–10-week-old female C57BL/6N mice once weekly with 0.9 mg of testosterone enanthate or a vehicle control for 6 weeks. All testosterone-treated mice stopped cycling and demonstrated persistent diestrus within 1 week of starting testosterone, while control mice cycled regularly. After 6 weeks of testosterone therapy, one group of testosterone-treated mice and age-matched vehicle-treated diestrus controls were sacrificed. Another group of testosterone-treated mice were maintained after stopping testosterone therapy and were sacrificed in diestrus four cycles after the resumption of cyclicity along with age-matched vehicle-treated controls. Ovarian histological analysis revealed stromal changes with clusters of large round cells in the post testosterone group as compared to both age-matched controls and mice at 6 weeks on testosterone. These clusters exhibited periodic acid–Schiff staining, which has been previously reported in multinucleated macrophages in aging mouse ovaries. Notably, many of these cells also demonstrated positive staining for macrophage markers CD68 and CD11b. Ovarian ribonucleic acid-sequencing found upregulation of immune pathways post testosterone as compared to age-matched controls and ovaries at 6 weeks on testosterone. Although functional significance remains unknown, further attention to the ovarian stroma may be relevant for transmasculine people interested in pausing testosterone to carry a pregnancy.

Summary Sentence

After testosterone is paused for reproductive purposes in a transgender mouse model, estrous cyclicity resumes, but ovaries demonstrate stromal aberrations and an upregulated inflammatory reaction.

Graphical Abstract

img-z2-2_802.jpg
Hadrian M. Kinnear, Prianka H. Hashim, Cynthia Dela Cruz, Faith L. Chang, Gillian Rubenstein, Likitha Nimmagadda, Venkateswaran Ramamoorthi Elangovan, Andrea Jones, Margaret A. Brunette, D. Ford Hannum, Jun Z. Li, Vasantha Padmanabhan, Molly B. Moravek, and Ariella Shikanov "Presence of ovarian stromal aberrations after cessation of testosterone therapy in a transgender mouse model," Biology of Reproduction 108(5), 802-813, (15 February 2023). https://doi.org/10.1093/biolre/ioad019
Received: 7 November 2022; Accepted: 10 February 2023; Published: 15 February 2023
KEYWORDS
immune
macrophage
Mouse
ovary
stroma
testosterone
transgender
RIGHTS & PERMISSIONS
Get copyright permission
Back to Top